MedPath

ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.

Not Applicable
Conditions
Uterine Neoplasms
Interventions
Procedure: ERAS protocol
Registration Number
NCT04063072
Lead Sponsor
Ospedale Regina Montis Regalis
Brief Summary

The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy of benign or malignant tumors of the uterus in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.

Detailed Description

ERAS (Enhanced Recovery After Surgery) protocol is a multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery. Even if efficacy and safety of ERAS protocol in gynaecological surgery is well-established in the literature, its implementation is limited to few selected centres in Piemonte. The aim of the study is to extend the implementation of the ERAS protocol to whole regional network of hospitals. Specific objectives are to estimate its impact on different dimensions of quality of care, including length of stay, complications and patient satisfaction, and to identify possible barriers or facilitating factors.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
1800
Inclusion Criteria
  • All the hospital wards within the Piemonte Region performing hysterectomy.
  • All the patients receiving an elective hysterectomy for benign or malignant tumors of the uterus.
Exclusion Criteria
  • Hospital wards performing less than 20 expected cases per year
  • Emergency hysterectomy
  • Hysterectomy for pelvic floor disorders
  • High severity cases not allowing ERAS protocol implementation (i.e. American Society of Anesthesiologists score: ASA V).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ERAS protocolERAS protocolPerioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to ERAS protocol.
Primary Outcome Measures
NameTimeMethod
Length of stay12 days after admission

Mean length of stay calculated as difference between date of discharge and date of admission of the hospitalization for surgery, excluding length of stay \>12 days (98th percentile of the expected distribution).

Secondary Outcome Measures
NameTimeMethod
Length of stay >12 days30 days after admission

Rate of patients with a length of stay \>12 days

Recovery after surgery24 hours after surgery

Score of quality of recovery at 24 hours after surgery, assessed with the questionnaire Quality of Recovery (QoR-15), a 15-items instrument, with responses recorded on a 11-point Likert-type scale form 0 (worst scenario) to 10 (best scenario) and an overall score ranging from 0 (poor recovery) to 150 (excellent recovery).

A visual analogue scale (VAS), ranging from 0 (worst imaginable health state) to 10 (worst imaginable health state) is also supplied as summary evaluation.

Complications30 days after discharge

Rate of surgical and medical complication after surgery For surgical complications: Comprehensive Complication Index

Emergency visits after discharge30 days after discharge

Rate of emergency visit in the first month after discharge

Transfer to intensive care unit30 days after surgery

Rate of transfers to intensive care unit after surgery

Hospital admissions after discharge30 days after discharge

Rate of new admissions in the first month after discharge

Reintervention30 days after surgery

Rate of reintervention in the first month after surgery, excluding planned interventions

Healthcare costs30 days after discharge

Mean healthcare costs from pre admission visit to 30 days after discharge

Patients' satisfaction15 days after discharge

Score of patients' satisfaction measured 2 weeks after discharge, assessed with the questionnaire Surgical Satisfaction Questionnaire (SSQ8) supplied by telephone. SSQ8 is a 8-items instrument, with responses recorded on a 5-point Likert-type scale from 0 (worst scenario) to 4 (best scenario) and an overall score ranging from 0 (very unsatisfied) to 32 (very satisfied).

Trial Locations

Locations (1)

Ospedale Regina Montis Regalis

🇮🇹

Mondovì, Italy

© Copyright 2025. All Rights Reserved by MedPath